Effect of low-level laser-treated mesenchymal stem cells on myocardial infarction
- PMID: 28681086
- DOI: 10.1007/s10103-017-2271-1
Effect of low-level laser-treated mesenchymal stem cells on myocardial infarction
Abstract
Cardiovascular disease is the leading cause of death worldwide. Although cardiac transplantation is considered the most effective therapy for end-stage cardiac diseases, it is limited by the availability of matching donors and the complications of the immune suppressive regimen used to prevent graft rejection. Application of stem cell therapy in experimental animal models was shown to reverse cardiac remodeling, attenuate cardiac fibrosis, improve heart functions, and stimulate angiogenesis. The efficacy of stem cell therapy can be amplified by low-level laser radiation. It is well established that the bio-stimulatory effect of low-level laser is influenced by the following parameters: wavelength, power density, duration, energy density, delivery time, and the type of irradiated target. In this review, we evaluate the available experimental data on treatment of myocardial infarction using low-level laser. Eligible papers were characterized as in vivo experimental studies that evaluated the use of low-level laser therapy on stem cells in order to attenuate myocardial infarction. The following descriptors were used separately and in combination: laser therapy, low-level laser, low-power laser, stem cell, and myocardial infarction. The assessed low-level laser parameters were wavelength (635-804 nm), power density (6-50 mW/cm2), duration (20-150 s), energy density (0.96-1 J/cm2), delivery time (20 min-3 weeks after myocardial infarction), and the type of irradiated target (bone marrow or in vitro-cultured bone marrow mesenchymal stem cells). The analysis focused on the cardioprotective effect of this form of therapy, the attenuation of scar tissue, and the enhancement of angiogenesis as primary targets. Other effects such as cell survival, cell differentiation, and homing are also included. Among the evaluated protocols using different parameters, the best outcome for treating myocardial infarction was achieved by treating the bone marrow by one dose of low-level laser with 804 nm wavelength and 1 J/cm2 energy density within 4 h of the infarction. This approach increased stem cell survival, proliferation, and homing. It has also decreased the infarct size and cell apoptosis, leading to enhanced heart functions. These effects were stable for 6 weeks. However, more studies are still required to assess the effects of low-level laser on the genetic makeup of the cell, the nuclei, and the mitochondria of mesenchymal stromal cells (MSCs).
Keywords: Cardiovascular diseases; Laser effects; Laser parameters; Low-level laser; Low-power laser; Stem cell.
Similar articles
-
Presenting a Method to Improve Bone Quality Through Stimulation of Osteoporotic Mesenchymal Stem Cells by Low-Level Laser Therapy.Photomed Laser Surg. 2017 Nov;35(11):622-628. doi: 10.1089/pho.2016.4245. Epub 2017 Jun 15. Photomed Laser Surg. 2017. PMID: 28621568 Review.
-
Combined effects of electromagnetic field and low-level laser increase proliferation and alter the morphology of human adipose tissue-derived mesenchymal stem cells.Lasers Med Sci. 2017 Jan;32(1):151-160. doi: 10.1007/s10103-016-2097-2. Epub 2016 Oct 21. Lasers Med Sci. 2017. PMID: 27770222
-
Mesenchymal Stem Cells Synergize with 635, 532, and 405 nm Laser Wavelengths in Renal Fibrosis: A Pilot Study.Photomed Laser Surg. 2016 Nov;34(11):556-563. doi: 10.1089/pho.2015.4025. Epub 2016 May 31. Photomed Laser Surg. 2016. PMID: 27244220
-
Effect of low-level laser therapy on mesenchymal stem cell proliferation: a systematic review.Lasers Med Sci. 2015 Nov;30(8):2189-94. doi: 10.1007/s10103-015-1730-9. Epub 2015 Mar 13. Lasers Med Sci. 2015. PMID: 25764448 Review.
-
Implantation of low-level laser irradiated mesenchymal stem cells into the infarcted rat heart is associated with reduction in infarct size and enhanced angiogenesis.Photomed Laser Surg. 2009 Apr;27(2):227-33. doi: 10.1089/pho.2008.2272. Photomed Laser Surg. 2009. PMID: 19382832
Cited by
-
Promoting Immortalized Adipose-Derived Stem Cell Transdifferentiation and Proliferation into Neuronal-Like Cells through Consecutive 525 nm and 825 nm Photobiomodulation.Stem Cells Int. 2022 Sep 5;2022:2744789. doi: 10.1155/2022/2744789. eCollection 2022. Stem Cells Int. 2022. PMID: 36106176 Free PMC article.
-
Photobiomodulation reduces hippocampal apoptotic cell death and produces a Raman spectroscopic "signature".PLoS One. 2022 Mar 3;17(3):e0264533. doi: 10.1371/journal.pone.0264533. eCollection 2022. PLoS One. 2022. PMID: 35239693 Free PMC article.
-
Effects of photobiomodulation on glucose homeostasis and morphometric parameters in pancreatic islets of diabetic mice.Lasers Med Sci. 2022 Apr;37(3):1799-1809. doi: 10.1007/s10103-021-03434-7. Epub 2021 Oct 4. Lasers Med Sci. 2022. PMID: 34604943
-
The Effect of Photobiomodulation on Human Mesenchymal Cells: A Literature Review.Aesthetic Plast Surg. 2021 Aug;45(4):1826-1842. doi: 10.1007/s00266-021-02173-y. Epub 2021 Feb 22. Aesthetic Plast Surg. 2021. PMID: 33616715 Review.
-
The Effect of Photobiomodulation Therapy on the Differentiation, Proliferation, and Migration of the Mesenchymal Stem Cell: A Review.J Lasers Med Sci. 2019 Fall;10(Suppl 1):S96-S103. doi: 10.15171/jlms.2019.S17. Epub 2019 Dec 1. J Lasers Med Sci. 2019. PMID: 32021681 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous